Personal information

No personal information available

Activities

Works (4)

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac<sup>®</sup>) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents

Vaccines
2024-08 | Journal article | Author
Contributors: Eddy Fadlyana; Kusnandi Rusmil; Muhammad Gilang Dwi Putra; Frizka Primadewi Fulendry; Nitta Kurniati Somantri; Alvira Dwilestarie Putri; Rini Sari; Mita Puspita; Gianita Puspita Dewi
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia

Vaccines
2024-04 | Journal article | Author
Contributors: Sharifah Shakinah; Hafiz aini; Rini Sekartini; Soedjatmiko; Bernie Endyarni Medise; Hartono Gunardi; Irene Yuniar; Wahyuni Indawati; Sukamto Koesnoe; Kuntjoro Harimurti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease

Vaccines
2024-02 | Journal article | Author
Contributors: Henhen Heryaman ; Cep Juli; Arnengsih Nazir; mas rizky A.A Syamsunarno; Badrul Yahaya; Dewi Kartika turbawaty; Rini Sari; Hikmat Permana; Rudi Supriyadi; nur atik
Source: check_circle
Multidisciplinary Digital Publishing Institute

Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–<i>Haemophilus influenza</i> B (Bio Farma) with Pentabio<sup>®</sup> Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants

Vaccines
2023-02 | Journal article | Author
Contributors: Eddy Fadlyana; Kusnandi Rusmil; Meita Dhamayanti; Rodman Tarigan; Cissy B. Kartasasmita; Rini Sari; Muhammad Gilang Dwi Putra; Hadyana Sukandar
Source: check_circle
Multidisciplinary Digital Publishing Institute